Landing
American Society of Retina Specialists (ASRS) 2025
Baseline Characteristics Associated with Geographic Atrophy Progression in the OAKS and DERBY Trials
Early Versus Delayed Pegcetacoplan Treatment for GA Secondary to AMD: 48 Month Results from OAKS, DERBY, and GALE Open-Label Extension
Fellow Eye Analysis in Bilateral GA due to AMD: Long-term Data from the OAKS, DERBY, and GALE Studies
A Descriptive Analysis of Patients Who Received Pegcetacoplan and Anti-VEGF for the Treatment of Geographic Atrophy and Neovascular AMD
Impact of AREDS Oral Micronutrient Supplementation on Geographic Atrophy Progression: Insights From the Phase 3 OAKS and DERBY Trials
The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.